Royal Philips Electronics N.V.
464 articles with Royal Philips Electronics N.V.
Philips showcases clinical data and solutions designed to deliver better cardiac care with greater efficiency at TCT 2022
Royal Philips, a global leader in health technology, will showcase its latest innovations and cardiology solutions designed to strengthen clinical confidence, build efficiency throughout the care pathway and improve cardiac care experiences at the Transcatheter Cardiovascular Therapeutics annual meeting.
Philips highlights FetView cloud-based image sharing and reporting software for obstetrics and gynecology at ISUOG 2022
Royal Philips, a global leader in health technology, announced the upcoming addition of the FetView cloud-based fetal ultrasound image sharing and reporting software for obstetrics/gynecology.
Philips announces new milestones in the development of the world’s first spectral detector angio CT solution
Royal Philips, a global leader in health technology, announced new milestones in the development of the world’s first spectral detector angio CT solution - Philips Spectral Angio CT suite - bringing the company’s breakthrough spectral CT imaging technology into an integrated hybrid angio CT suite.
Philips Respironics alerts customers worldwide of updated instructions and labeling of specific sleep therapy masks that contain magnetic headgear clips due to potential risk of serious injury
Royal Philips’ subsidiary Philips Respironics is alerting users of certain CPAP or Bi-Level PAP therapy masks with magnetic headgear clips or straps that these devices should not be used by or near patients and their household members, caregivers and bed partners who have metallic implanted devices or metallic objects in the body.
Baptist Health’s Miami Cardiac & Vascular Institute successfully treats its first cardiac patients with new 3D Philips Intracardiac Echocardiography Catheter
Royal Philips, a global leader in health technology, announced that Baptist Health’s Miami Cardiac & Vascular Institute has successfully started treating patients with Verisight Pro, Philips’ real-time 3D Intracardiac Echocardiography catheter, during minimally-invasive image-guided procedures for structural heart disease.
Royal Philips, a global leader in health technology, will showcase its latest integrated cardiology solutions at the European Society of Cardiology Congress.
Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer
Royal Philips convenes an Extraordinary General Meeting of Shareholders and publishes the agenda with explanatory note.
Amsterdam, the Netherlands - Royal Philips, a global leader in health technology, announced that Roy Jakobs is proposed to succeed Frans van Houten as President and Chief Executive Officer, effective October 15, 2022.
Royal Philips, a global leader in health technology, will showcase its award-winning AI-powered systems and solutions debuting at the European Congress of Radiology.
Royal Philips, a global leader in health technology, announced its SmartSpeed artificial intelligence powered MR acceleration software has received U.S. Food and Drug Administration 510 clearance.
Amsterdam, the Netherlands – Royal Philips announced that it has completed the cancellation of 8,758,455 of its shares.
Philips Signs Health Care Sector Pledge to Reduce Emissions as part of Department of Health and Human Services, White House Initiative
Royal Philips announced the company has joined an initiative created by the Department of Health and Human Services, in partnership with the White House, to address climate action through the reduction of greenhouse gas emissions.
Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program
On June 14, 2021, RoyalPhilips’ subsidiary Philips Respironics, initiated a voluntary recall notification/field safety notice* to address potential health risks related to the polyester-based polyurethane sound abatement foam in specific CPAP, BiPAP and mechanical ventilator devices.
Philips to repurchase up to 3.2 million shares to cover long-term incentive and employee stock purchase plans
Amsterdam, the Netherlands – Royal Philips announced that it will repurchase up to 3.2 million shares to cover certain of its obligations arising from its long-term incentive and employee stock purchase plans.
Philips announces positive three-year clinical research results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial
Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty II below-the-knee clinical trial, demonstrating that the Philips endovascular system – Tack – the first and only device of its kind approved by the U.S. Food and Drug Administration, provides a sustained treatment effect and positive impact on quality of life for patients with critical limb ischemia, a severe stage of peripheral arterial disease, out to three years of clinical follow-up.
Philips’ Future Health Index 2022 report shows healthcare leaders are rebooting priorities as they emerge from the pandemic
Royal Philips announced the publication of its Future Health Index 2022 report: ‘Healthcare hits reset: Priorities shift as healthcare leaders navigate a changed world’.
Royal Philips, a global leader in health technology, announced that Willem Appelo will join Philips’ Executive Committee, effective July 18, 2022, and succeed Sophie Bechu as Chief Operations Officer per October 1, 2022.
Royal Philips announced that the exchange ratio for the dividend in shares for the year 2021 has been determined.
Royal Philips, a global leader in health technology, is showcasing innovations at EuroPCR that can enable interventionists to perform ultra-low contrast percutaneous coronary intervention procedures with greater confidence and clarity.
New release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency
Royal Philips, a global leader in health technology, announced at EuroPCR the international launch of EchoNavigator 4.0 , the new release of its advanced image-guided therapy solution for the treatment of structural heart disease.